摘要 |
A method of treating an Hepatitis C Virus infection in a patient, comprising providing a therapeutically effective amount, to a patient in need thereof, of a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein: G1 is a group of the formula or where n is 0, 1, 2, 3, or 4 and Het is a 5- or 6-membered heteroaryl group containing 1 to 4 heteroatoms independently chosen from N, O, and S, which Het is optionally substituted. |
申请人 |
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;PROVID PHARMACEUTICALS, INC.;SELF, CHRISTOPHER;ZHANG, GUANGTAO;POMMIER, YVES;SHOEMAKER, ROBERT H.;CURRENS, MICHAEL;CARDELLINA, JOHN;JOBSON, ANDREW;LOUNTOS, GEORGE;SCUDIERO, DOMINIC A.;WAUGH, DAVID |
发明人 |
SELF, CHRISTOPHER;ZHANG, GUANGTAO;POMMIER, YVES;SHOEMAKER, ROBERT H.;CURRENS, MICHAEL;CARDELLINA, JOHN;JOBSON, ANDREW;LOUNTOS, GEORGE;SCUDIERO, DOMINIC A. |